Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella spp. associated with bovine respiratory disease

Journal of Veterinary Diagnostic Investigation

Volumn 8, Issue 3, 1996, Pages 337-344

  Shryock, Thomas R ^a   White, Donald W ^a   Staples, J Mitchell ^a   Werner, Carolyn S ^b  

^a ELANCO ANIMAL HEALTH   (United States)

^b CAVL Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DRUG DERIVATIVE; ERYTHROMYCIN; MACROLIDE; TILMICOSIN; TYLOSIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; CATTLE; CATTLE DISEASE; COMPARATIVE STUDY; DRUG EFFECT; GRAM NEGATIVE INFECTION; ISOLATION AND PURIFICATION; MANNHEIMIA HAEMOLYTICA; MICROBIOLOGICAL EXAMINATION; PASTEURELLA; PASTEURELLA MULTOCIDA; PATHOGENICITY; PREDICTION AND FORECASTING; REPRODUCIBILITY;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CATTLE DISEASES; ERYTHROMYCIN; MACROLIDES; MANNHEIMIA HAEMOLYTICA; MICROBIAL SENSITIVITY TESTS; PASTEURELLA; PASTEURELLA INFECTIONS; PASTEURELLA MULTOCIDA; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; TYLOSIN;

EID: 0030178640     PISSN: 10406387     EISSN: None     Source Type: Journal    
DOI: 10.1177/104063879600800310     Document Type: Article

References (34)

1. Allen, JW, Viel L, Bateman KG, et al.: 1991, The microbial flora of the respiratory tract in feedlot calves: associations between naso-phargngeal and bronchoalveolar lavage culture. Can J Vet Res 55:341-346.
2. Bradford PA, Sanders CC: 1992, Use of a predictor panel for development of a new disk for diffusion tests with cefoperazone-sulbactam. Antimicrob Agents Chemother 36:394-400.
3. Butts JD: 1994, Intracellular concentrations of antibacterial agents and related clinical impressions. Clin Pharmacokinet Concepts 27:63-84.
4. Debono M, Willard KE, Kirst HA, et al.: 1989, Synthesis and antimicrobial evaluation of 20-deoxo-20-(3,5-dimethylpiperidin-1-yl)desmycosin (tilmicosin, EL-870) and related cyclic amino derivatives. J Antibiot 13:1253-1267.
5. Diarra MS, Malouin F: 1994, Postantibiotic effects of tilmicosin and of other antibacterial agents at MICs and sub-MICs on swine and bovine pathogens. Proc Annu Meet Am Soc Microbiol 94:16. [Abstr. A-81]
6. Fodor L, Varga J, Gallowitsch F, et al.: 1993, Treatment of calf pneumonia with tilmicosin. Acta Vet Hung 41:41-49.
7. Galyean ML, Gunter SA, Malcolm-Callis KJ: 1995, Effects of arrival medication with tilmicosin phosphate on health and performance of newly received beef-cattle. J Anim Sci 73:1219-1226.
8. Gavan TL, Jones RN, Barry AL: 1980, Evaluation of the Sensititre system for quantitative antimicrobial drug susceptibility testing: a collaborative study. Antimicrob Agents Chemother 17:464-469.
9. Gladue RP, Brigh GM, Isaacson RE, Newborg MF: 1989, In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob Agents Chemother 33:277-282.
10. Gorham PE, Carroll LH, McAskill JW, et al.: 1990, Tilmicosin as a single injection treatment for respiratory disease of feedlot cattle. Can Vet J 31:826-829.
11. Gourlay RN, Thomas LH, Wyld SG, Smith C: 1989, Effect of a new macrolide antibiotic (tilmicosin) on pneumonia experimentally induced in calves by Mycoplasma bovis and Pasteurella haemolytica. Res Vet Sci 47:84-89.
12. Hartman EG, Geryl J: 1993, Comparison between the minimal inhibitory concentration of tilmicosin and oxytetracycline for bovine pneumonic Pasteurella haemolytica isolates. Vet Q 15: 184.
13. Kirst HA, Willard KE, Debono M, et al.: 1989, Structure-activity studies of 20-deoxo-20-amino derivatives of tylosin-related macrolides. J Antibiot 17:1673-1683.
14. Laven R, Andrews AH: 1991, Long-acting antibiotic formulations in the treatment of calf pneumonia: a comparative study of tilmicosin and oxytetracycline. Vet Rec 129:109-111.
15. Lawrence K: 1994, An evaluation of the efficacy of tilmicosin in the treatment of bacterial pneumonia in European cattle. Proc Int Congr Eur Assoc Vet Pharmacol Ther 6:000-000.
16. Mechor GD, Jim GK, Janzen EG: 1988, Comparison of penicillin, oxytetracycline, and trimethoprim-sulfadoxine in the treatment of acute undifferentiated bovine respiratory disease. Can Vet J 29:438-443.
17. Merrill JK, Tonkinson LV: 1989, The effectiveness of Micotil for the treatment of bovine respiratory disease. Bovine Pract 24:26-28.
18. Morck DW, Merrill JK, Thorlakson BE: 1993, Prophylactic efficacy of tilmicosin for bovine respiratory tract disease. J Am Vet Med Assoc 202:273-277.
19. Mortensen JE, Shryock TR: 1994, Veterinary antimicrobial susceptibility testing coming of age. Clin Microbiol Newsl 16(16): 134-135.
20. National Committee for Clinical Laboratory Standards: 1992, Development of in vitro susceptibility testing criteria and quality control parameters, 2nd ed., Tentative guideline M23-T2. NCCLS, Villanova, PA.
21. National Committee for Clinical Laboratory Standards: 1993, Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed., Approved standard M7-A3. NCCLS, Villanova, PA.
22. National Committee for Clinical Laboratory Standards: 1993, Performance standards for antimicrobial disk susceptibility tests, 5th ed., Approved standard M2-A5. NCCLS, Villanova, PA.
23. Ose EE: 1987, In vitro antibacterial properties of EL-870, a new semi-synthetic macrolide antibiotic. J. Antibiot 15:190-194.
24. Ose EE, Tonkinson LV: 1988, Single-dose treatment of neonatal calf pneumonia with the new macrolide antibiotic tilmicosin. Vet Rec 123:367-369.
25. Phillips I, Warren C, Waterworth P: 1978, Determination of antibiotic sensitivities by the Sensititre system. J Clin Pathol 31:531-535.
26. Post KW, Cole NA, Raleigh RH: 1991, In vitro antimicrobial susceptibility of Pasteurella haemolytica and Pasteurella multocida recovered from cattle with bovine respiratory disease complex. J Vet Diagn Invest 3:124-126.
27. Shryock TR, White DW, Werner CS, Staples JM: 1995, Proposed quality control guidelines for antimicrobial susceptibility tests using tilmicosin. J Clin Microbiol 33:331-335.
28. Thomson TD, Laudert SB, Chamberland S, Lawrence K: 1994, Micotil - pharmacokinetics of tilmicosin, a semi-synthetic macrolide antibiotic. Proc Int Congr Eur Assoc Vet Pharmacol. Ther 6.
29. Thomson TD, Lawrence K: 1994, Micotil: pharmacokinetics of tilmicosin, a semi-synthetic macrolide, in cattle. Int Congr Eur Assoc Vet Pharmacol Ther 6.
30. Thomson TD, Matsuoka T: 1989, Correlation of lung concentrations of a new veterinary antimicrobial with efficacy against Pasteurella haemolytica pneumonia in feedlot cattle. Proc Annu Meet Conf Res Workers Anim Dis 70:199.
31. Van Koevering MT, Smith RA, Gill DR, Owens FN: 1992, Effects of tilmicosin or ceftiofur sodium on health and performance of shipping-stressed calves. J Anim Sci 70:90.
32. Watts JL, Yancy RJ Jr, Salmon SA, Case CA: 1994, A 4-year survey of antimicrobial susceptibility trends for isolates from cattle with bovine respiratory disease in North America. J Clin Microbiol 32:725-731.
33. Watts JT, Yancy RJ Jr: 1994, Identification of veterinary pathogens by use of commercial identification systems and new trends in antimicrobial susceptibility testing of veterinary pathogens. Clin Microbiol Rev 7:346-356.
34. Woolfrey BF, Fox JM, Quail CO, Lally RT: 1983, Error rates associated with the use of recently proposed breakpoints for testing Pseudomonas aeruginosa versus gentamicin, tobramycin, and amikacin by the standardized disk agar diffusion test. Antimicrob Agents Chemother 24:764-770.